Blood Cancer Discovery | American Association for Cancer Research

Skip Nav Destination

Current Issue

Volume 4,

Issue 6

1 November 2023

About the Journal

Blood Cancer Discovery provides a critical outlet for high-impact basic, translational, and clinical research on all disease subtypes of leukemia, lymphoma, myeloma, and associated diseases. Read More About the Journal

Editors-in-Chief

Riccardo Dalla-Favera
Kenneth C. Anderson

View Full Editorial Board

Impact Factor

11.4

SUBMIT TO JOURNAL

Featured Articles

Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells

Annika Nelde, et al.

IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies

Guido Lancman, et al.

Clinical Correlates of Venetoclax-Based Combination Sensitivities to Augment Acute Myeloid Leukemia Therapy

Christopher A. Eide, et al.

Trending - Altmetric

The article titled, Understanding Infection Risk with Anti-BCMA Bispecific Antibodies, has an Alt Metric Attention Score of 69.8. Click to see more of this article's metrics.

Read the article titled, Understanding Infection Risk with Anti-BCMA Bispecific Antibodies

Last mentioned on Wednesday November 29 2023

The article titled, Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19, has an Alt Metric Attention Score of 45.65. Click to see more of this article's metrics.

Read the article titled, Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19

Last mentioned on Sunday December 3 2023

The article titled, Extracellular Vesicle Secretion by Leukemia Cells In Vivo Promotes CLL Progression by Hampering Antitumor T-cell Responses, has an Alt Metric Attention Score of 8.65. Click to see more of this article's metrics.

Read the article titled, Extracellular Vesicle Secretion by Leukemia Cells In Vivo Promotes CLL Progression by Hampering Antitumor T-cell Responses

Last mentioned on Wednesday November 29 2023

The article titled, ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple Myeloma, has an Alt Metric Attention Score of 13.7. Click to see more of this article's metrics.

Read the article titled, ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple Myeloma

Last mentioned on Monday November 27 2023

The article titled, A Year of Advances in Precision Therapy for Blood Cancers, has an Alt Metric Attention Score of 1.35. Click to see more of this article's metrics.

Read the article titled, A Year of Advances in Precision Therapy for Blood Cancers

Last mentioned on Monday November 27 2023

Latest
Most Read
Most Cited

Product attributes of CAR T-cell therapy differentially associate with efficacy and toxicity in second-line large B-cell lymphoma (ZUMA-7)

ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple Myeloma

Criteria for diagnosis and molecular monitoring of NPM1-mutated AML

Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells

The Twitter live feed is not currently active.

Keep up to date with Blood Cancer Discovery

Follow @BCD_AACR

About the Journal

Editors-in-Chief

Impact Factor

Featured Articles

Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells

IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies

Clinical Correlates of Venetoclax-Based Combination Sensitivities to Augment Acute Myeloid Leukemia Therapy

Trending - Altmetric

Keep up to date with Blood Cancer Discovery

AACR Journals

This Feature Is Available To Subscribers Only